ClinicalTrials.gov
public full text
Public Domain
Multiple Ascending Doses (MAD) of Anti-A Disintegrin and Metalloproteinase With Thrombospondin Motifs-5 (Anti-ADAMTS-5) Nanobody in Participants With Knee Osteoarthritis (OA)
The study will be conducted in participants with symptomatic knee OA to explore the safety, tolerability, immunogenicity, pharmacokinetics (PK), and pharmacodynamics (PD) of MAD of M6495.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Correlating the Osteoarthritic Knee Microenvironment to Clinical Outcome After Treatment With Regenexx®SD Treatment#1074170
- Mesenchymal Stem Cells Derived Exosomes in Osteoarthritis Patients#838327
- Antiarthritis Effect Of A Novel Bruton's Tyrosine Kinase (BTK) Inhibitor In Rat Collagen-Induced Arthritis And Mechanism-Based Pharmacokinetic/Pharmacodynamic Modeling: Relationships Between Inhibition Of BTK Phosphorylation And Efficacy#19602
- Genetically informed search for potential osteoarthritis drug targets across the proteome#422497
- nSTRIDE APS in Females With Primary Patellofemoral Osteoarthritis#871478
Record · ID 897767
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive